Seliciclib (R-roscovitine) induces apoptosis in undifferentiated nasopharyngeal cancer (NPC) in vivo and in vitro


Autoria(s): Goh, B.C.; Peh, B.K.; Cui, C.Y.; Soo, R.; Loh, T.; Green, S.; Hsieh, W.S.; Lai, K.F.; Salto-Tellez, Manuel; Mow, B.
Data(s)

01/05/2005

Identificador

http://pure.qub.ac.uk/portal/en/publications/seliciclib-rroscovitine-induces-apoptosis-in-undifferentiated-nasopharyngeal-cancer-npc-in-vivo-and-in-vitro(833bec0c-26c2-406f-afc2-a0e69001a0d2).html

Idioma(s)

eng

Direitos

info:eu-repo/semantics/restrictedAccess

Fonte

Goh , B C , Peh , B K , Cui , C Y , Soo , R , Loh , T , Green , S , Hsieh , W S , Lai , K F , Salto-Tellez , M & Mow , B 2005 , ' Seliciclib (R-roscovitine) induces apoptosis in undifferentiated nasopharyngeal cancer (NPC) in vivo and in vitro ' Journal of Clinical Oncology , vol 23 , pp. 227S-227S .

Tipo

article